Pregnancy triggers profound hormonal reorganization across the maternal body to support fetal growth and prepare for parturition and lactation. The placenta, pituitary, thyroid, adrenals, and parathyroid glands all alter their baseline secretory patterns. These widespread chemical adjustments influence almost every organ system, altering metabolism, fluid balance, and vascular tone. Midwives must understand that these profound physiological shifts explain many common physical discomforts pregnant women experience during routine antenatal visits.
Once established, the placenta functions as a dominant endocrine gland, producing both protein and steroid hormones.
The anterior pituitary gland enlarges during pregnancy, largely driven by the hyperplasia of estrogen-stimulated lactotroph cells. Despite this physical growth, the secretion of most anterior pituitary hormones, such as luteinizing hormone and follicle-stimulating hormone, is suppressed due to high circulating levels of estrogen and progesterone. Conversely, prolactin levels rise dramatically throughout gestation to prepare the mammary glands for lactation, increasing up to tenfold by term. The posterior pituitary releases oxytocin in increasing amounts near term, while baseline secretion of antidiuretic hormone helps regulate maternal fluid retention.
Maternal thyroid glands undergo moderate enlargement during pregnancy due to glandular hyperplasia and increased vascularity. Renal clearance of iodine increases, which can lower total serum iodine levels and mildly stimulate the thyroid to work harder. Total thyroxine ($T_4$) and triiodothyronine ($T_3$) rise because estrogen prompts the liver to produce more thyroid-binding globulin. However, the amount of free, active thyroid hormone remains largely within the normal non-pregnant range, ensuring normal maternal and fetal metabolic homeostasis.
The adrenal cortex enlarges during pregnancy, leading to elevated circulating levels of cortisol and aldosterone. Free plasma cortisol increases significantly, helping the maternal body manage the metabolic stress of gestation and contributing to the insulin resistance seen in later pregnancy. Meanwhile, aldosterone production increases markedly to help retain sodium and expand extracellular fluid volume, matching the expanded vascular needs of the uteroplacental unit.
Fetal skeletal development places a heavy demand on maternal calcium stores, requiring major adjustments in calcium regulation. Maternal parathyroid hormone-related peptide (PTHrP), produced by the placenta and breast tissue, helps mobilize calcium from maternal bone and enhances renal calcium reabsorption. Although total serum calcium drops because of decreased binding proteins, ionized calcium—the physiologically active form—remains tightly regulated and normal throughout pregnancy.
Endocrine changes cause numerous physical signs that can mimic pathology if a midwife is unfamiliar with normal adaptations. For instance, mild palmar erythema and spider angiomas occur due to high estrogen levels, while slight thyroid enlargement is a normal variant. Midwives must interpret laboratory values carefully, knowing that reference ranges for hormones and metabolic markers differ substantially in pregnant women compared to non-pregnant populations.